MK-6621-051

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-6621-051, covering 2014-01-30 to 2014-01-30. Get the full timeline:

Most recent: Clinical Trial Update: International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)